“…The voice changes associated with Danazol treatment include lowering of fundamental frequency (F o )' increased frequency variability (Mercaitis et aI., 1985), voice instability, loss of high frequency, creakiness and hoarseness (Gerritsma et aI., 1994), reduced pitch control and lower pitch (Damste, 1967;Wardle and Whitehead, 1983;Baker, 1999), inflammation ' (Boothroyd and Lepre, 1990) and grey discoloration of the vocai folds (Damste, 1967). Many of these studies have relied on case study reports (Damste, 1967;Wardle and Whitehead, 1983;Mercaitis et aI., 1985;Boothroyd and Lepre, 1990;Baker, 1999) and have documented only perceptual findings (Hamblen, 1957;Epstein and Bridger, 1983;Wardle and Whitehead, 1983;Boothroyd and Lepre, 1990;Newman and Forbes, 1993).…”